ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Pharmacogenomics May Lead To Individualized Treatment

June 25, 2004

Cancer Program Critics Called “Irresponsible,” Demagogues”

March 21, 1975

MIT Radiation Poisoning Was Deliberate, NRC Investigation Finds

December 15, 1995

Varmus Wins ASCO’s Science Of Oncology Award; Sawyers To Give Karnofsky Lecture.

January 28, 2005

Grossman Leads Neuro-Oncology Society; NYU Recruits Radiation Oncology Director.

January 14, 2000

NCI to Expand Quality of Care Research, Lead HHS Panel On Cancer Care Policy.

October 1, 1999